Skip to main content
Realcan Pharmaceutical Group Co.,Ltd. logo

Realcan Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 002589 ISIN · CNE1000013X5 LEI · 300300YI5IV3FBRRSJ48 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,678 across all filing types
Latest filing 2019-04-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002589

About Realcan Pharmaceutical Group Co.,Ltd.

https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. specializes in the distribution of pharmaceutical products, medical devices, and healthcare consumables. The company operates an extensive supply chain network, providing integrated logistics and distribution services primarily to medical institutions and healthcare providers. Its core operations include the procurement, storage, and delivery of a wide range of medical supplies, supported by advanced information management systems and cold-chain logistics capabilities. Realcan also offers value-added services such as hospital supply chain optimization, third-party logistics, and financial solutions tailored to the healthcare industry. By focusing on a direct-to-hospital distribution model, the company aims to enhance the efficiency of medical supply procurement and ensure the timely delivery of critical healthcare products.

Recent filings

Filing Released Lang Actions
内部控制规则落实自查表
Regulatory Filings Classification · 95% confidence The document is titled as an "内部控制规则落实自查表" which translates to "Internal Control Rules Implementation Self-Inspection Form." It contains detailed internal control checklists related to audit operations, information disclosure, insider trading controls, fundraising controls, related party transactions, external guarantees, major investments, and other important matters. The document is a self-assessment or compliance checklist rather than a financial report or announcement. It does not contain financial statements, earnings data, or regulatory filings such as annual or interim reports. It is also not a certification or a short announcement but a detailed internal control compliance document. This type of document fits best under Regulatory Filings (RNS) as it is a compliance-related disclosure that does not fit other specific categories like Annual Report, Audit Report, or Management Reports.
2019-04-29 Chinese
关于修订公司章程的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the revision of the company's articles of association (公司章程). It details specific amendments to the articles, referencing compliance with updated laws and stock exchange rules. The document is relatively short (2158 characters) and serves as a formal notice of these changes, including that the amendments will be submitted to the 2018 annual general meeting for approval. There are no financial statements, audit information, or detailed financial data present. This is not a full annual report, interim report, or any financial report. It is also not a proxy solicitation or voting results announcement, but rather a regulatory announcement about governance document changes. Therefore, the best fitting category is Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2019-04-29 Chinese
关于会计政策变更和会计报表格式调整的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 瑞康医药集团股份有限公司 regarding changes in accounting policies and adjustments to the financial statement formats. It references a regulatory notice from the Ministry of Finance dated June 15, 2018, and details specific changes in accounting classifications and presentation. The document includes board and supervisory committee approvals and independent director opinions. The length is 1784 characters, which is relatively short and the content is focused on announcing the accounting policy changes rather than presenting full financial statements or detailed financial data. There is no indication that this is a full annual or interim report, nor is it a certification or a voting result announcement. It is a formal announcement of accounting policy changes and related board approvals, which fits best under Regulatory Filings (RNS) as it does not contain full financial statements or detailed financial analysis but is a compliance-related disclosure.
2019-04-29 Chinese
关于举行2018年年度报告网上说明会的公告
Investor Presentation Classification · 95% confidence The document is a short announcement (593 characters) about a scheduled online meeting to explain the 2018 annual report. It states that the 2018 annual report was already published on April 30, 2019, and the meeting is to provide further explanation to investors. There is no actual financial data or report content in this document, only an invitation to a presentation event. According to the 'Menu vs Meal' rule, this is not the annual report itself but an announcement related to it. The document fits the description of an Investor Presentation (IP) as it is a detailed presentation event for investors focusing on financials and company information.
2019-04-29 Chinese
2019年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled "2019 年第一季度报告全文" which translates to "2019 First Quarter Report Full Text." It contains detailed financial data including consolidated and parent company balance sheets, profit and loss statements, cash flow analysis, and explanations of financial changes during the quarter. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year (the first quarter of 2019) clearly indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-04-29 Chinese
2019年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2019 First Quarter Report" of 瑞康医药集团股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as income, net profit, cash flow, assets, liabilities, and shareholder information for the first quarter of 2019. The length of the document (7247 characters) and the presence of comprehensive financial statements and analysis confirm it is a substantive financial report rather than a brief announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-04-29 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.